The global Personalized Medicines market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
3G Biotech
Quest Diagnostics
Laboratory Corporation of America
Abbott
Agendia NV
Asuragen Inc
Becton Dickinson
CardioDx Inc.
Foundation Medicine
Qiagen
Siemens Healthcare
Amgen
Bristol-Myers Squibb
GE Healthcare
Pfizer
Sanofi
23andMe
Illumina
By Types:
PM Diagnostics
PM Therapeutics
Personalized Medical Care
Personalized Nutrition & Wellness
By Applications:
Hospitals Pharmacies
Retail Pharmacies
Dietary Care Centers
Others
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Personalized Medicines Market Size Analysis from 2023 to 2028
1.5.1 Global Personalized Medicines Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Personalized Medicines Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Personalized Medicines Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Personalized Medicines Industry Impact
Chapter 2 Global Personalized Medicines Competition by Types, Applications, and Top Regions and Countries
2.1 Global Personalized Medicines (Volume and Value) by Type
2.1.1 Global Personalized Medicines Consumption and Market Share by Type (2017-2022)
2.1.2 Global Personalized Medicines Revenue and Market Share by Type (2017-2022)
2.2 Global Personalized Medicines (Volume and Value) by Application
2.2.1 Global Personalized Medicines Consumption and Market Share by Application (2017-2022)
2.2.2 Global Personalized Medicines Revenue and Market Share by Application (2017-2022)
2.3 Global Personalized Medicines (Volume and Value) by Regions
2.3.1 Global Personalized Medicines Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Personalized Medicines Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Personalized Medicines Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Personalized Medicines Consumption by Regions (2017-2022)
4.2 North America Personalized Medicines Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Personalized Medicines Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Personalized Medicines Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Personalized Medicines Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Personalized Medicines Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Personalized Medicines Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Personalized Medicines Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Personalized Medicines Sales, Consumption, Export, Import (2017-2022)
4.10 South America Personalized Medicines Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Personalized Medicines Market Analysis
5.1 North America Personalized Medicines Consumption and Value Analysis
5.1.1 North America Personalized Medicines Market Under COVID-19
5.2 North America Personalized Medicines Consumption Volume by Types
5.3 North America Personalized Medicines Consumption Structure by Application
5.4 North America Personalized Medicines Consumption by Top Countries
5.4.1 United States Personalized Medicines Consumption Volume from 2017 to 2022
5.4.2 Canada Personalized Medicines Consumption Volume from 2017 to 2022
5.4.3 Mexico Personalized Medicines Consumption Volume from 2017 to 2022
Chapter 6 East Asia Personalized Medicines Market Analysis
6.1 East Asia Personalized Medicines Consumption and Value Analysis
6.1.1 East Asia Personalized Medicines Market Under COVID-19
6.2 East Asia Personalized Medicines Consumption Volume by Types
6.3 East Asia Personalized Medicines Consumption Structure by Application
6.4 East Asia Personalized Medicines Consumption by Top Countries
6.4.1 China Personalized Medicines Consumption Volume from 2017 to 2022
6.4.2 Japan Personalized Medicines Consumption Volume from 2017 to 2022
6.4.3 South Korea Personalized Medicines Consumption Volume from 2017 to 2022
Chapter 7 Europe Personalized Medicines Market Analysis
7.1 Europe Personalized Medicines Consumption and Value Analysis
7.1.1 Europe Personalized Medicines Market Under COVID-19
7.2 Europe Personalized Medicines Consumption Volume by Types
7.3 Europe Personalized Medicines Consumption Structure by Application
7.4 Europe Personalized Medicines Consumption by Top Countries
7.4.1 Germany Personalized Medicines Consumption Volume from 2017 to 2022
7.4.2 UK Personalized Medicines Consumption Volume from 2017 to 2022
7.4.3 France Personalized Medicines Consumption Volume from 2017 to 2022
7.4.4 Italy Personalized Medicines Consumption Volume from 2017 to 2022
7.4.5 Russia Personalized Medicines Consumption Volume from 2017 to 2022
7.4.6 Spain Personalized Medicines Consumption Volume from 2017 to 2022
7.4.7 Netherlands Personalized Medicines Consumption Volume from 2017 to 2022
7.4.8 Switzerland Personalized Medicines Consumption Volume from 2017 to 2022
7.4.9 Poland Personalized Medicines Consumption Volume from 2017 to 2022
Chapter 8 South Asia Personalized Medicines Market Analysis
8.1 South Asia Personalized Medicines Consumption and Value Analysis
8.1.1 South Asia Personalized Medicines Market Under COVID-19
8.2 South Asia Personalized Medicines Consumption Volume by Types
8.3 South Asia Personalized Medicines Consumption Structure by Application
8.4 South Asia Personalized Medicines Consumption by Top Countries
8.4.1 India Personalized Medicines Consumption Volume from 2017 to 2022
8.4.2 Pakistan Personalized Medicines Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Personalized Medicines Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Personalized Medicines Market Analysis
9.1 Southeast Asia Personalized Medicines Consumption and Value Analysis
9.1.1 Southeast Asia Personalized Medicines Market Under COVID-19
9.2 Southeast Asia Personalized Medicines Consumption Volume by Types
9.3 Southeast Asia Personalized Medicines Consumption Structure by Application
9.4 Southeast Asia Personalized Medicines Consumption by Top Countries
9.4.1 Indonesia Personalized Medicines Consumption Volume from 2017 to 2022
9.4.2 Thailand Personalized Medicines Consumption Volume from 2017 to 2022
9.4.3 Singapore Personalized Medicines Consumption Volume from 2017 to 2022
9.4.4 Malaysia Personalized Medicines Consumption Volume from 2017 to 2022
9.4.5 Philippines Personalized Medicines Consumption Volume from 2017 to 2022
9.4.6 Vietnam Personalized Medicines Consumption Volume from 2017 to 2022
9.4.7 Myanmar Personalized Medicines Consumption Volume from 2017 to 2022
Chapter 10 Middle East Personalized Medicines Market Analysis
10.1 Middle East Personalized Medicines Consumption and Value Analysis
10.1.1 Middle East Personalized Medicines Market Under COVID-19
10.2 Middle East Personalized Medicines Consumption Volume by Types
10.3 Middle East Personalized Medicines Consumption Structure by Application
10.4 Middle East Personalized Medicines Consumption by Top Countries
10.4.1 Turkey Personalized Medicines Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Personalized Medicines Consumption Volume from 2017 to 2022
10.4.3 Iran Personalized Medicines Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Personalized Medicines Consumption Volume from 2017 to 2022
10.4.5 Israel Personalized Medicines Consumption Volume from 2017 to 2022
10.4.6 Iraq Personalized Medicines Consumption Volume from 2017 to 2022
10.4.7 Qatar Personalized Medicines Consumption Volume from 2017 to 2022
10.4.8 Kuwait Personalized Medicines Consumption Volume from 2017 to 2022
10.4.9 Oman Personalized Medicines Consumption Volume from 2017 to 2022
Chapter 11 Africa Personalized Medicines Market Analysis
11.1 Africa Personalized Medicines Consumption and Value Analysis
11.1.1 Africa Personalized Medicines Market Under COVID-19
11.2 Africa Personalized Medicines Consumption Volume by Types
11.3 Africa Personalized Medicines Consumption Structure by Application
11.4 Africa Personalized Medicines Consumption by Top Countries
11.4.1 Nigeria Personalized Medicines Consumption Volume from 2017 to 2022
11.4.2 South Africa Personalized Medicines Consumption Volume from 2017 to 2022
11.4.3 Egypt Personalized Medicines Consumption Volume from 2017 to 2022
11.4.4 Algeria Personalized Medicines Consumption Volume from 2017 to 2022
11.4.5 Morocco Personalized Medicines Consumption Volume from 2017 to 2022
Chapter 12 Oceania Personalized Medicines Market Analysis
12.1 Oceania Personalized Medicines Consumption and Value Analysis
12.2 Oceania Personalized Medicines Consumption Volume by Types
12.3 Oceania Personalized Medicines Consumption Structure by Application
12.4 Oceania Personalized Medicines Consumption by Top Countries
12.4.1 Australia Personalized Medicines Consumption Volume from 2017 to 2022
12.4.2 New Zealand Personalized Medicines Consumption Volume from 2017 to 2022
Chapter 13 South America Personalized Medicines Market Analysis
13.1 South America Personalized Medicines Consumption and Value Analysis
13.1.1 South America Personalized Medicines Market Under COVID-19
13.2 South America Personalized Medicines Consumption Volume by Types
13.3 South America Personalized Medicines Consumption Structure by Application
13.4 South America Personalized Medicines Consumption Volume by Major Countries
13.4.1 Brazil Personalized Medicines Consumption Volume from 2017 to 2022
13.4.2 Argentina Personalized Medicines Consumption Volume from 2017 to 2022
13.4.3 Columbia Personalized Medicines Consumption Volume from 2017 to 2022
13.4.4 Chile Personalized Medicines Consumption Volume from 2017 to 2022
13.4.5 Venezuela Personalized Medicines Consumption Volume from 2017 to 2022
13.4.6 Peru Personalized Medicines Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Personalized Medicines Consumption Volume from 2017 to 2022
13.4.8 Ecuador Personalized Medicines Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Personalized Medicines Business
14.1 3G Biotech
14.1.1 3G Biotech Company Profile
14.1.2 3G Biotech Personalized Medicines Product Specification
14.1.3 3G Biotech Personalized Medicines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Quest Diagnostics
14.2.1 Quest Diagnostics Company Profile
14.2.2 Quest Diagnostics Personalized Medicines Product Specification
14.2.3 Quest Diagnostics Personalized Medicines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Laboratory Corporation of America
14.3.1 Laboratory Corporation of America Company Profile
14.3.2 Laboratory Corporation of America Personalized Medicines Product Specification
14.3.3 Laboratory Corporation of America Personalized Medicines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Abbott
14.4.1 Abbott Company Profile
14.4.2 Abbott Personalized Medicines Product Specification
14.4.3 Abbott Personalized Medicines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Agendia NV
14.5.1 Agendia NV Company Profile
14.5.2 Agendia NV Personalized Medicines Product Specification
14.5.3 Agendia NV Personalized Medicines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Asuragen Inc
14.6.1 Asuragen Inc Company Profile
14.6.2 Asuragen Inc Personalized Medicines Product Specification
14.6.3 Asuragen Inc Personalized Medicines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Becton Dickinson
14.7.1 Becton Dickinson Company Profile
14.7.2 Becton Dickinson Personalized Medicines Product Specification
14.7.3 Becton Dickinson Personalized Medicines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 CardioDx Inc.
14.8.1 CardioDx Inc. Company Profile
14.8.2 CardioDx Inc. Personalized Medicines Product Specification
14.8.3 CardioDx Inc. Personalized Medicines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Foundation Medicine
14.9.1 Foundation Medicine Company Profile
14.9.2 Foundation Medicine Personalized Medicines Product Specification
14.9.3 Foundation Medicine Personalized Medicines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Qiagen
14.10.1 Qiagen Company Profile
14.10.2 Qiagen Personalized Medicines Product Specification
14.10.3 Qiagen Personalized Medicines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Siemens Healthcare
14.11.1 Siemens Healthcare Company Profile
14.11.2 Siemens Healthcare Personalized Medicines Product Specification
14.11.3 Siemens Healthcare Personalized Medicines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 Amgen
14.12.1 Amgen Company Profile
14.12.2 Amgen Personalized Medicines Product Specification
14.12.3 Amgen Personalized Medicines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 Bristol-Myers Squibb
14.13.1 Bristol-Myers Squibb Company Profile
14.13.2 Bristol-Myers Squibb Personalized Medicines Product Specification
14.13.3 Bristol-Myers Squibb Personalized Medicines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.14 GE Healthcare
14.14.1 GE Healthcare Company Profile
14.14.2 GE Healthcare Personalized Medicines Product Specification
14.14.3 GE Healthcare Personalized Medicines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.15 Pfizer
14.15.1 Pfizer Company Profile
14.15.2 Pfizer Personalized Medicines Product Specification
14.15.3 Pfizer Personalized Medicines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.16 Sanofi
14.16.1 Sanofi Company Profile
14.16.2 Sanofi Personalized Medicines Product Specification
14.16.3 Sanofi Personalized Medicines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.17 23andMe
14.17.1 23andMe Company Profile
14.17.2 23andMe Personalized Medicines Product Specification
14.17.3 23andMe Personalized Medicines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.18 Illumina
14.18.1 Illumina Company Profile
14.18.2 Illumina Personalized Medicines Product Specification
14.18.3 Illumina Personalized Medicines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Personalized Medicines Market Forecast (2023-2028)
15.1 Global Personalized Medicines Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Personalized Medicines Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Personalized Medicines Value and Growth Rate Forecast (2023-2028)
15.2 Global Personalized Medicines Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Personalized Medicines Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Personalized Medicines Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Personalized Medicines Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Personalized Medicines Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Personalized Medicines Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Personalized Medicines Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Personalized Medicines Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Personalized Medicines Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Personalized Medicines Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Personalized Medicines Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Personalized Medicines Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Personalized Medicines Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Personalized Medicines Consumption Forecast by Type (2023-2028)
15.3.2 Global Personalized Medicines Revenue Forecast by Type (2023-2028)
15.3.3 Global Personalized Medicines Price Forecast by Type (2023-2028)
15.4 Global Personalized Medicines Consumption Volume Forecast by Application (2023-2028)
15.5 Personalized Medicines Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
| Price : US$ 3500 |
Date : May 2024 |
| Category : Services |
Pages : 120 |
| Price : US$ 2450 |
Date : Jan 2024 |
| Category : Electronics |
Pages : 274 |
Request Sample 
Request Discount 
Inquire Before Buy
